The Roquette Foundation for Health supports the Pasteur Institute of Paris in its LuLISA research project, for a more accessible diagnosis of food allergies, directly from a general practitioner.
Working since 1887, the Paris Pasteur Institute is a non-profit foundation whose mission is to contribute to the prevention and treatment of diseases, primarily infectious diseases. At the heart of scientific progress, the Paris Pasteur Institute carries out four major missions of general interest: research, teaching, the health of populations and individuals, and the development of innovation and technology transfer.
The LuLISA (Luciferas-Linked Immunosorbent Assay) project aims to develop a rapid and accessible method for the diagnosis of various food allergies in a general practitioner’s office, using a few drops of blood. This method is based on a new generation of markers, the luciferases, whose signals are thousands of times more intense than those produced by enzymes in current diagnostics. By using bioluminescence to quantify patients’ immunoglobulins, diagnosis will be facilitated and patients will be treated more safely.
In the current context, Institut Pasteur has also adapted the project to monitor the progression of herd immunity against Covid 19 disease.
Ultimately, the LuLISA project will identify allergies in order to orient and inform allergic patients more quickly and clearly, to accurately assess the risks in order to propose a treatment and to limit the risks related to allergies encountered during hospitalization. The research process will be faster, safer for the patient and available at a more accessible cost.